Literature DB >> 31483535

Understanding the links between cardiovascular disease and Parkinson's disease.

Judy Potashkin1, Xuemei Huang2, Claudia Becker3, Honglei Chen4, Thomas Foltynie5, Connie Marras6.   

Abstract

Studies investigating the associations between genetic or environmental factors and Parkinson's disease (PD) have uncovered a number of factors shared with cardiovascular disease, either as risk factors or manifestations of cardiovascular disease itself. Older age, male sex, and possibly type 2 diabetes are examples. On the other hand, coffee consumption and physical activity are each associated with a lower risk of both PD and cardiovascular disease. This observation raises questions about the underlying pathophysiological links between cardiovascular disease and PD. There is evidence for common mechanisms in the areas of glucose metabolism, cellular stress, lipid metabolism, and inflammation. On the other hand, smoking and total/low-density lipoprotein cholesterol appear to have opposite associations with cardiovascular disease and PD. Thus, it is uncertain whether the treatment of cardiovascular risk factors will impact on the onset or progression of PD. The available data suggest that a nuanced approach is necessary to manage risk factors such as cholesterol levels once the associations are better understood. Ultimately, the choice of therapy may be tailored to a patient's comorbidity profile. This review presents the epidemiological evidence for both concordant and discordant associations between cardiovascular disease and PD, discusses the cellular and metabolic processes that may underlie these links, and explores the implications this has for patient care and future research.
© 2019 International Parkinson and Movement Disorder Society. © 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; cardiovascular; pathogenesis; risk factors

Year:  2019        PMID: 31483535      PMCID: PMC6981000          DOI: 10.1002/mds.27836

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  159 in total

1.  Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease.

Authors:  Gülnur Andican; Dildar Konukoglu; Melda Bozluolcay; Kemal Bayülkem; Sinem Firtiına; Gülden Burcak
Journal:  Acta Neurol Belg       Date:  2012-02-09       Impact factor: 2.396

Review 2.  Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis.

Authors:  Katsiaryna Bykov; Kazuki Yoshida; Marc G Weisskopf; Joshua J Gagne
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-08-16       Impact factor: 2.890

3.  Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression.

Authors:  Woojin Scott Kim; Glenda M Halliday
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568

4.  Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease.

Authors:  Ingemar Björkhem; Anita Lövgren-Sandblom; Valerio Leoni; Steve Meaney; Lovisa Brodin; Lisette Salveson; Kristian Winge; Sven Pålhagen; Per Svenningsson
Journal:  Neurosci Lett       Date:  2013-09-10       Impact factor: 3.046

Review 5.  Cardiac abnormalities in Parkinson's disease and Parkinsonism.

Authors:  Fulvio A Scorza; Ana C Fiorini; Carla A Scorza; Josef Finsterer
Journal:  J Clin Neurosci       Date:  2018-04-26       Impact factor: 2.116

6.  Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.

Authors:  Bram P Prins; Ali Abbasi; Anson Wong; Ahmad Vaez; Ilja Nolte; Nora Franceschini; Philip E Stuart; Javier Guterriez Achury; Vanisha Mistry; Jonathan P Bradfield; Ana M Valdes; Jose Bras; Aleksey Shatunov; Chen Lu; Buhm Han; Soumya Raychaudhuri; Steve Bevan; Maureen D Mayes; Lam C Tsoi; Evangelos Evangelou; Rajan P Nair; Struan F A Grant; Constantin Polychronakos; Timothy R D Radstake; David A van Heel; Melanie L Dunstan; Nicholas W Wood; Ammar Al-Chalabi; Abbas Dehghan; Hakon Hakonarson; Hugh S Markus; James T Elder; Jo Knight; Dan E Arking; Timothy D Spector; Bobby P C Koeleman; Cornelia M van Duijn; Javier Martin; Andrew P Morris; Rinse K Weersma; Cisca Wijmenga; Patricia B Munroe; John R B Perry; Jennie G Pouget; Yalda Jamshidi; Harold Snieder; Behrooz Z Alizadeh
Journal:  PLoS Med       Date:  2016-06-21       Impact factor: 11.069

7.  Integrated molecular landscape of Parkinson's disease.

Authors:  J E Visser; G Poelmans; C J H M Klemann; G J M Martens; M Sharma; M B Martens; O Isacson; T Gasser
Journal:  NPJ Parkinsons Dis       Date:  2017-04-10

8.  Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.

Authors:  Xuejing Yue; Hehua Li; Haiqing Yan; Ping Zhang; Li Chang; Tong Li
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

9.  Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk.

Authors:  Lijun Zhang; Xue Wang; Ming Wang; Nick W Sterling; Guangwei Du; Mechelle M Lewis; Tao Yao; Richard B Mailman; Runze Li; Xuemei Huang
Journal:  Front Neurol       Date:  2017-09-27       Impact factor: 4.003

Review 10.  Functional morphology of the blood-brain barrier in health and disease.

Authors:  Stefan Liebner; Rick M Dijkhuizen; Yvonne Reiss; Karl H Plate; Dritan Agalliu; Gabriela Constantin
Journal:  Acta Neuropathol       Date:  2018-02-06       Impact factor: 17.088

View more
  22 in total

Review 1.  Epidemiological Evidence for an Immune Component of Parkinson's Disease.

Authors:  Paulina Gonzalez-Latapi; Connie Marras
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

2.  Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.

Authors:  Robin M Voigt; Zeneng Wang; J Mark Brown; Phillip A Engen; Ankur Naqib; Christopher G Goetz; Deborah A Hall; Leo Verhagen Metman; Maliha Shaikh; Christopher B Forsyth; Ali Keshavarzian
Journal:  Neurobiol Dis       Date:  2022-05-30       Impact factor: 7.046

3.  DNA methylation-based surrogates of plasma proteins are associated with Parkinson's disease risk.

Authors:  Katherine A Fu; Kimberly C Paul; Ake T Lu; Steve Horvath; Adrienne M Keener; Yvette Bordelon; Jeff M Bronstein; Beate Ritz
Journal:  J Neurol Sci       Date:  2021-11-03       Impact factor: 4.553

4.  Cognition, motor symptoms, and glycolipid metabolism in Parkinson's disease with depressive symptoms.

Authors:  Cong Yao; Lichao Niu; Yun Fu; Xu Zhu; Junfeng Yang; Peng Zhao; Xiaoxiao Sun; Yanyan Ma; Shen Li; Jie Li
Journal:  J Neural Transm (Vienna)       Date:  2021-11-27       Impact factor: 3.850

5.  The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson's Disease.

Authors:  Nicol G M Oonk; Kris L L Movig; Job van der Palen; Henk-Willem Nijmeijer; Mirjam E van Kesteren; Lucille D A Dorresteijn
Journal:  Clin Drug Investig       Date:  2021-08-10       Impact factor: 2.859

6.  Dietary Factors and Neurodegenerative Disorders: An Umbrella Review of Meta-Analyses of Prospective Studies.

Authors:  Janett Barbaresko; Arno Werner Lellmann; Annemarie Schmidt; Andreas Lehmann; Anna Maria Amini; Sarah Egert; Sabrina Schlesinger; Ute Nöthlings
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

Review 7.  Cardiac Involvement in Movement Disorders.

Authors:  Malco Rossi; Nestor Wainsztein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2021-04-07

8.  Perfect Storm: COVID-19 Associated Cardiac Injury and Implications for Neurological Disorders.

Authors:  Catherine Ruth Jutzeler; Thomas Edward Nightingale; Andrei Vasilievich Krassioukov; Matthias Walter
Journal:  Neurotrauma Rep       Date:  2020-07-23

9.  The Role of Intermittent Fasting in Parkinson's Disease.

Authors:  Bryan J Neth; Brent A Bauer; Eduardo E Benarroch; Rodolfo Savica
Journal:  Front Neurol       Date:  2021-06-01       Impact factor: 4.003

10.  Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.

Authors:  Ting Wang; Feilan Yuan; Zhenze Chen; Shuzhen Zhu; Zihan Chang; Wanlin Yang; Bin Deng; Rongfang Que; Peihua Cao; Yinxia Chao; Lingling Chan; Ying Pan; Yanping Wang; Linting Xu; Qiurong Lyu; Piu Chan; Midori A Yenari; Eng-King Tan; Qing Wang
Journal:  Aging (Albany NY)       Date:  2020-08-15       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.